Post-ICU Syndrome: Identifying Challenges and Improving Mortality
Post-ICU syndrome includes psychological effects — depression, anxiety, and PTSD — as well as worsened physical functioning.
Acute Pain
ACUTE PAIN
Feature Article
Latest
Multipronged Postop Opioid Program Reduces Prescription Length
A systemwide, multipronged pain management and opioid reduction program can significantly reduce opioid discharge prescriptions written for more than five days.
FDA Approves Meloxicam Injection for Moderate to Severe Pain
The FDA has approved Anjeso (meloxicam injection; Baudax Bio) for the management of moderate to severe pain, alone or in combination with NSAIDs in adult patients.
FDA Approves OTC Switch of Diclofenac Topical Gel
Diclofenac sodium topical gel and olopatadine HCl ophthalmic drops will soon be available over-the-counter (OTC) after the the Food and Drug Administration (FDA) switched the status of these products from prescription to nonprescription.
Production of Two Excedrin Painkillers Halted
Production and distribution of Excedrin Extra Strength and Excedrin Migraine products have been temporarily stopped.
Ibuprofen Injection Now Available in Ready-to-Use Bags for Pain Relief
A ready-to-use formulation of Caldolor (ibuprofen injection) has been made available by Cumberland Pharmaceuticals.
Early Regional Anesthesia Effective for Extremity Injury Pain
Regional anesthesia may aid pain management if used soon after traumatic injury of the extremities.
NDA Submitted for IV Tramadol for Inpatient Pain Management
The application includes data from two phase 3 clinical trials in patients following bunionectomy and abdominoplasty surgeries.
G-Protein Mu Opioid Receptor Agonist Effective for Acute Pain
If approved, the Company expects that the drug would be classified as a Schedule II controlled substance.
Higher Total Testosterone Levels Linked to Less Pain in Severe Knee OA
Higher serum testosterone levels were associated with less WOMAC pain in the operated knee in both men and women, and less WOMAC disability in women.
Changes in Opioid Prescription Patterns Among US Gastroenterologists
Though gastroenterologists are prescribing fewer opioids for Medicare patients, they should also prescribe more neuromodulators because there is more high-quality evidence supporting their efficacy for conditions causing chronic abdominal pain conditions.
Want to read more?
Please login or register first to view this content.
Next post in Post-Surgical Pain
